Nicolet Advisory Services LLC Has $285,000 Position in Bath & Body Works, Inc. (NYSE:BBWI)

Nicolet Advisory Services LLC cut its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 9.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 7,824 shares of the company’s stock after selling 797 shares during the quarter. Nicolet Advisory Services LLC’s holdings in Bath & Body Works were worth $285,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of BBWI. Golden State Wealth Management LLC acquired a new stake in shares of Bath & Body Works in the 4th quarter valued at approximately $26,000. SRS Capital Advisors Inc. boosted its position in shares of Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after purchasing an additional 329 shares in the last quarter. UMB Bank n.a. grew its holdings in shares of Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after buying an additional 335 shares during the period. Lindbrook Capital LLC increased its position in shares of Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after buying an additional 431 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Bath & Body Works during the 3rd quarter worth $39,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Down 2.6 %

NYSE:BBWI opened at $27.11 on Friday. Bath & Body Works, Inc. has a twelve month low of $25.41 and a twelve month high of $52.99. The firm has a market capitalization of $5.81 billion, a price-to-earnings ratio of 6.61, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. The stock’s 50 day moving average price is $34.45 and its two-hundred day moving average price is $34.10.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. The business had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.95%. Bath & Body Works’s dividend payout ratio (DPR) is currently 21.98%.

Bath & Body Works declared that its Board of Directors has authorized a share repurchase program on Thursday, February 27th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 6.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

Wall Street Analysts Forecast Growth

BBWI has been the subject of a number of research analyst reports. Citigroup raised Bath & Body Works from a “neutral” rating to a “buy” rating and boosted their target price for the company from $40.00 to $48.00 in a research note on Friday, February 28th. Raymond James reiterated an “outperform” rating and issued a $46.00 price objective (up from $42.00) on shares of Bath & Body Works in a research report on Tuesday, February 25th. Wells Fargo & Company upgraded shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Robert W. Baird upped their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an “outperform” rating in a report on Friday, February 28th. Finally, Piper Sandler raised their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a report on Monday, January 6th. Five analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works has an average rating of “Moderate Buy” and a consensus price target of $45.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.